Clinical studies of multiple endocrine neoplasia type 1 (MEN1)

QJM: An International Journal of Medicine

Volumn 89, Issue 9, 1996, Pages 653-669

  Trump, D ^a   Farren, B ^a   Wooding, C ^a   Pang, J T ^a   Besser, G M ^b   Buchanan, K D ^c   Edwards, C R ^d   Heath, D A ^e   Jackson, C E ^f   Jansen, S ^g   Lips, K ^h   Monson, J P ^b   O'Halloran, D ⁱ   Sampson, J ^j   Shalet, S M ⁱ   Wheeler, M H ^k   Zink, A ^l   Thakker, R V ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^e SELLY OAK HOSPITAL   (United Kingdom)

^f HENRY FORD HOSPITAL   (United States)

^g UNIVERSITY OF THE FREE STATE   (South Africa)

^h Academisch Ziekenhuis Utrecht   (Netherlands)

ⁱ WITHINGTON HOSPITAL   (United Kingdom)

^j UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^k Cardiff Royal Infirmary   (United Kingdom)

^l UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADENOHYPOPHYSIS; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHILD; CONTROLLED STUDY; FEMALE; GASTRINOMA; HUMAN; HYPOPHYSIS TUMOR; INSULINOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS ISLET CELL TUMOR; PARATHYROID TUMOR; PRIORITY JOURNAL; SCREENING;

EID: 0001710006     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.9.653     Document Type: Article

References (27)

1. Thakker RV, Ponder BAJ. Multiple endocrine neoplasia. In: Sheppard MC, ed. Clinical Endocrinology and Metabolism, vol. 2. London, Bailliere Tindall, 1988: 1031-67.
2. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954; 16:362-3.
3. Ballard HS, Frame B, Hartstock RJ. Familial multiple endocrine adenoma-peptic ulcer complex. Medicine 1964; 43:481-515.
4. Lips CM, Vasen HFA, Lamers CBHW. Multiple endocrine neoplasia syndromes. CRC Crit Rev Oncol Haematol 1984; 2:117-84.
5. Calender A, Giraud S, Cougard P, Chanson P, Lenoir G, Murat A, Hamon P, Proye C. Multiple endocrine neoplasia type 1 in France: clinical and genetic studies. J Intern Med 1995; 238:263-8.
6. Benson L, Ljunghall S, Åkerstrom G, Oberg K. Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. Am J Med 1987; 82:731-7.
7. Marx SJ, Vinik AI, Santen RJ, Floyd JC, Mills JL, Green J. Multiple endocrine neoplasia type 1: Assessment of laboratory tests to screen for the gene in a large kindred. Medicine 1986; 65(4):226-41.
8. Majewski JT, Wilson SD. The MEA-1 syndrome: an all or none phenomenon. Surgery 1979; 86:474-84.
9. Eberle F, Grun R. Multiple endocrine neoplasia type 1 (MEN1). Ergbeg Inn Med Kinderheilkd 1981; 46:76-149.
10. Marx SJ, Spiegel AM, Levine MA, Rizzoli RE, Lasker RD, Santora AC, Downs RW Jr, Aurbach GD. Familial hypocalciuric hypercalcaemia; the relation to primary parathyroid hyperplasia. N Engl J Med 1982; 307:416-26.
11. Skogseid B, Larsson C, Lindgren P-G, Kvanta E, Rastad J, Theodorsson E, Wide L, Wilander E, Oberg K. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1992; 75(1):76-81.
12. Dun Q-Y, Hybarger CP, Geist R, Gamsu G, Goodman PC, Gooding GAW, Clark OH. Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 1987; 154:142-8.
13. O'Halloran DJO, Shalet SM. A family pedigree exhibiting features of both multiple endocrine neoplasia type 1 and McCune-Albright Syndromes. J Clin Endocrinol Metab 1994; 78(3):523-5.
14. Thakker RV, Fraher LJ, Adami S, Karmali R, O'Riordan JL. Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism. J Bone Min Res 1986; 1:137-44.
15. Webster J, Pisciteelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinaemic amenorrhoea. N Engl J Med 1994; 331:904-9.
16. Knudson AG. Mutation and Cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68(4):820-3.
17. Service FJ, Dale AJD, Elveback LR, Jiang N-S. Insulinoma: Clinical and diagnostic features of 60 cases. Mayo Clinic Proc 1976; 51:417-29.
18. Vasen HFA, Lamers CBHW, Lips CJM. Screening for the multiple endocrine neoplasia syndrome type 1. Arch Intern Med 1989; 149:2717-22.
19. Croisier JC, Azerod E, Lubetzki J. L'adenomatose polyendocrinienne (syndrome de Wermer). A propos d'une observation personelle et revue de la literature. Semin Hop Paris 1971; 47:494-525.
20. Skogseid B, Eriksson B, Lundqvist G, Lorelius E, Rastad J, Wide L, Åkerstrom G, Oberg K. Multiple endocrine neoplasia type 1: A 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991; 73(2):281-7.
21. Knudson AG, Strong LC. Mutation and cancer: a model for Wilm's tumor of the kidney. J Natl Cancer Inst 1972; 48:313-24.
22. Knudson AG, Strong LC. Mutation and cancer: neuroblastoma and phaeochromocytoma. Am J Hum Genet 1972; 24:514-32.
23. Maher E, Yates JRW, Ferguson-Smith MA. Statistical analysis of the two-stage model in von Hippel Lindau disease, and in sporadic cerebellar and renal cell carcinoma. J Med Genet 1990; 27:311-14.
24. Pang JT, Lloyd SE, Wooding C, Farren B, Pottinger B, Harding B, Leigh SEA, Pook MA, Benham FJ, Gillett GT, Taggart RT, Thakker RV. Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of m-calpain as the multiple endocrine neoplasia type 1 gene. Hum Genet 1996; 97: 732-41.
25. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988; 332:85-7.
26. Thakker RV, Bouloux P, Wooding C, Chotal K, Broad PM, Spurr NK, Besser GM, O'Riordan JLH. Association of parathroid tumours in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 1989; 321:218-24.
27. Thakker RV. The role of molecular genetics in screening for multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 1994; 23(1):117-35.